News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on MedAdvisor.
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
Rise and Shine: What you need to know before the ASX opens
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Report calls for long-term investment in pandemic R&D
Health & Biotech
Mesoblast burnt $108m in FY20 waiting on key FDA ruling
Health & Biotech
MedAdvisor eyes off US health insurance market with new distribution deal
Health & Biotech
The healthcare winners and losers after COVID-19, and what comes next
Health & Biotech
Investors can’t get enough of telehealth as global funding surges in Q3
Director Trades
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m
Tech
The tech stocks analysts reckon will do well in the coronavirus crisis
News
Lunchtime ASX small cap wrap: Who’s staying calm (for now)?
Health & Biotech
Check up: Cashing in on deals done long ago
Health & Biotech
Dr Boreham’s Crucible: MedAdvisor could cure what ails it by shelving its expansion plans
News
Corporate: This small cap is launching a medication delivery service
Health & Biotech
Health: Admedus shares fly 40pc on first trading day in six months
Health & Biotech
